Kevin Lowdermilk - 04 Mar 2026 Form 4 Insider Report for VSEE HEALTH, INC. (VSEE)

Reporting relationship: Director
Issuer ticker: VSEE
Reported as of: 04 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Mar 2026, 16:32:42 UTC
Prior SEC filing: 03 Mar 2026
Next SEC filing: 27 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Kevin Lowdermilk

Key filing fact

Kevin Lowdermilk filed Form 4 for VSEE HEALTH, INC. (VSEE) on 05 Mar 2026.

Key facts

This page summarizes Kevin Lowdermilk's Form 4 filing for VSEE HEALTH, INC. (VSEE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Mar 2026, 16:32.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001952688 Primary reporting owner

LOWDERMILK KEVIN

Relationship: Director
Address: C/O VSEE HEALTH, INC., 980 N FEDERAL HWY #304, BOCA RATON
Signature: /s/ Kevin Lowdermilk
Signature date: 05 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VSEE transaction

Common Stock, par value $0.0001 per share

Award

Transaction value
Shares: +40,107
Change %: +58%
Price: $0.3740^*
Shares after: 108,731
Date: 04 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects shares of common stock issued to the reporting person under the issuer's 2024 Incentive Plan in accordance with the issuer's non-employee director compensation policy for services as a director during the quarter ended December 31, 2025. The number of shares issued to the reporting person is based on the closing price of the common stock on December 31, 2025.